SCHMC

SCHMC Repository

Browsing by Author : 김한조

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

or enter first few letters:

Sort by:
In order:
Results/Page
Etal:

Showing results 1 to 60 of 84

1 Article A case of septic pulmonary embolism associated with renal abscess mimicking pulmonary metastases of renal malignancy 이상미 ; 김한조 ; 장시형 ; et al 2014
2 Article A Multicenter Retrospective Analysis of the Clinical Features of Pernicious Anemia in a Korean Population 김한조 ; 배상병 ; 이규택 2013
3 Conference A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer 김한조 ; 이상철 ; 배상병 ; et al 2014
4 Article A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study 이규택 ; 배상병 ; 김한조 2015
5 Conference A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer 김한조 ; 이상철 ; 배상병 ; et al 2018
6 Conference A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746) 김한조 2019
7 Conference A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial 김한조 2024
8 Article Abstract 708: Defensin-alpha 6 (DEFA6) as a protumorigenic function in vitro and prognostic marker in colorectal cancer 정동준 ; 김한조 ; 안태성 ; et al 2016
9 Article Abstract 709: In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients 정동준 ; 김한조 ; 안태성 ; et al 2016
10 Article Abstract P1-16-01: Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer: A randomized, open-label, multicenter, phase II trial (KCSG-BR15-17) 김한조 2022
11 Article Abstract P5-16-03: Phase II study of trastuzumab biosimilar (Herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (BR 18-13, KM-10A): Interim analysis 김한조 2022
12 Article Angiogenic marker associated with resistance to neoadjuvant chemoradiotherapy in rectal cancer 김한조 ; 안태성 ; 이상철 ; et al 2013
13 Article Antibody response to variants during Omicron outbreak after BNT162b2 booster in Korean healthcare workers 김한조 2022
14 Article Antiemetic effect of palonosetron and first-generation serotonin inhibitors in combination with aprepitant and dexamethasone 김한조 2022
15 Conference Antiemetic effectiveness of palonosetron and first-generation serotonin inhibitors for high emetic risk chemotherapy in the post-aprepitant era 김한조 ; 이상철 ; 배상병 ; et al 2012
16 Article Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer 김한조 ; 백무준 ; 강동현 ; et al 2018
17 Conference Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer 이상철 ; 이규택 ; 배상병 ; et al 2016
18 Article Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study 이상철 ; 이규택 ; 배상병 ; et al 2018
19 Article Busulfan, Melphalan and Etoposide Followed by Autologous Stem Cell Transplantation on Patients with Non-Hodgkin's Lymphoma: Multicenter Study From Consortium for Improving Survival of Lymphoma (CISL) in Korea 김한조 2011
20 Article Clinical outcome of gastric cancer patients with bone marrow metastases 김한조 ; 배상병 ; 이규택 2011
21 Article Clinical Outcome of Patients with Myelophthisic Anemia Arising From Advanced Gastric Cancer 김한조 ; 배상병 ; 이규택 2009
22 Article Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP 김한조 2023
23 Article Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast Cancer 이지혜_병리과 ; 배상병 ; 오미혜 ; et al 2017
24 Article CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer 김한조 ; 손명원 ; 안태성 ; et al 2018
25 Article Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer 강동현 ; 이현용 ; 안태성 ; et al 2019
26 Conference Defensin-alpha 6 (DEFA6) as a protumorigenic function in vitro and prognostic marker in colorectal cancer 김한조 ; 안태성 ; 전섭 ; et al 2016
27 Article Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer 김한조 2011
28 Article Epigenetic inactivation of RUNX3 in colorectal cancer 김한조 ; 손명원 ; 안태성 ; et al 2018
29 Article Expression of AMP-activated protein kinase/ten-eleven translocation 2 and their clinical relevance in colorectal cancer 강동현 ; 안태성 ; 이현용 ; et al 2021
30 Article Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer 배상병 ; 조현득 ; 오미혜 ; et al 2016
31 Article Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients With Colorectal Cancer 정해일 ; 안태성 ; 김한조 ; et al 2017
32 Article Fever of unknown origin caused by hemophagocytic lymphohistiocytosis associated with diffuse large B-cell lymphoma 김민선 ; 김보현 ; 김한조 ; et al 2023
33 Article Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial 김한조 ; 이상철 ; 배상병 ; et al 2021
34 Article Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer 김한조 2023
35 Article Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab 김한조 ; 배상병 2014
36 Conference In vitro functional study of Ang 2 in colorectal cancer cell line and the significance of Ang 2 expression in colorectal cancer patients 백무준 ; 김창진 ; 김한조 ; et al 2014
37 Conference In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients 김한조 ; 안태성 ; 전섭 ; et al 2016
38 Article Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis 김한조 ; 배상병 ; 이규택 ; et al 2016
39 Article Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer 안태성 ; 김한조 ; 배상병 ; et al 2017
40 Article Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer 조현득 ; 이종은 ; 오미혜 ; et al 2015
41 Article Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma 장시형 ; 오미혜 ; 조현득 ; et al 2019
42 Article Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines 이상철 ; 김한조 ; 배상병 ; et al 2011
43 Conference Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer 이상철 ; 이규택 ; 배상병 ; et al 2015
44 Conference Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer 이규택 ; 배상병 ; 김한조 2014
45 Article Multicenter Retrospective Analysis of High Dose Chemotherapy and Autologous PBSCT for Ovarian Cancer 김한조 2009
46 Article MYH9 nephropathy 이규택 ; 김한조 ; 이지혜_호흡기알레르기내과 ; et al 2015
47 Conference Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15) 김한조 2024
48 Article Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma 안태성 ; 배상병 ; 김한조 ; et al 2017
49 Conference Overexpression of nuclear karyopherin alpha2 correlates with poor prognosis in patients with colorectal cancer 백무준 ; 김창진 ; 김한조 ; et al 2014
50 Article Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study 김한조 2025
51 Article Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial 김한조 2019
52 Article Pathophysiological role of hormones and cytokines in cancer cachexia 김한조 ; 이상철 ; 배상병 ; et al 2012
53 Article Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) 김한조 2020
54 Conference PEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancer 김한조 2017
55 Article Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial 김한조 2024
56 Article Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer 김한조 ; 배상병 ; 이규택 2011
57 Article Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients 김한조 ; 이태훈 ; 이상철 ; et al 2012
58 Article Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B) 김한조 2022
59 Article Practical Experience of Thromboprophylaxis After Lower Limb Replacement - Rivaroxaban Versus Enoxaparin 김한조 ; 배상병 2012
60 Article Prevalence of Anemia and Treatment Outcomes after Bariatric Surgery-a Retrospective Korean Study 김한조 ; 이상철 ; 배상병 ; et al 2015

1 2 > >>

OAK SCHMC Repository was built as a OAK to the National Central Library.